Background: There is limited evidence about the psychometric properties of field tests to measure cardiorespiratory fitness in people with Down syndrome.
Objective: This study aimed at analyzing the reliability and convergent validity of the 6-min run test when performed by young adults with Down syndrome (DS).
Methods: In a cross-sectional design fifty-one young adults with DS (mean age 26.20 ± 7.14 years; 54% women) performed the 6-min run test and the 16-min shuttle run test twice with a one week-interval between test and retest.
Results: The 6-min run test offered high reliability for the distances covered (ICC: 0.974; 95% CI: 0.955-0.985) and good reliability when comparing peak heart rate values obtained in the test and retest (ICC: 0.870; 95% CI: 0.772-0.926). A significant correlation between the 6-min run test and the 16-min shuttle run test was observed for the test (r = 0.705; Sig = 0.001), and retest phases (r = 0.651; Sig = 0.001). The relationship between the estimated maximal oxygen consumption (VO max) peak after the performance of the 16-min shuttle run test and the distance covered by the 6-min run test was statistically significant (r > 0.7). No significant differences were found between the equations that estimate VO peak for both tests.
Conclusions: These findings suggest that the 6-min run test shows high test/retest reliability and moderate to moderately high convergent validity when performed by adults with DS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.dhjo.2016.07.004 | DOI Listing |
Neurotrauma Rep
January 2025
Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.
Exercise to treat traumatic brain injury (TBI) is a novel approach that has only become recognized in the past decade. High-intensity gait training (HIGT) has been studied in subjects following stroke; however, little research investigates similar protocols on patients with TBI. The study evaluated HIGT as an intervention for enhancing patient recovery after TBI.
View Article and Find Full Text PDFDiabetol Int
January 2025
Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Aims: To clarify the long-term effects of short-term exercise instructions by physical therapists in Japanese people with type 2 diabetes (T2D).
Methods: This was a follow-up study of 2 years after randomized controlled study of short-term exercise instructions included 18 patients (5 in the non-intervention and 13 in the intervention groups). Motor skills, including 6 min walk test scores, and transtheoretical model was evaluated at baseline (week 0) the end of the study of the previous study (week 8), and 2 years after (2 years).
ERJ Open Res
January 2025
Department of Smoking and COPD Research, National Institute of Respiratory Diseases, Mexico City, Mexico.
Background: COPD ranks as the third leading global cause of mortality. Despite the widespread use of the BODE index and its variants for mortality prediction, their accuracy may be affected by factors like ethnicity, altitude and regional disparities. This study aimed to assess a new altitude-adapted prognostic index in COPD patients at moderate altitudes compared with the BODE and other mortality predictors.
View Article and Find Full Text PDFClin Cardiol
January 2025
Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Background: Endothelial function (EndFx) is a core component of cardiovascular (CV) health and cardioprotection following acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention (PCI).
Hypothesis: AMI patients experience endothelial dysfunction (EndDys), associated with traditional CV risk factors and sleep patterns. EndFx may also predict short and mid-term outcomes.
Eur J Heart Fail
January 2025
Medical University of South Carolina, Charleston, SC, USA.
Aims: Early identification and management of worsening heart failure (HF) is necessary to prevent disease progression and hospitalizations. The ALLEVIATE-HF (Algorithm Using LINQ Sensors for Evaluation and Treatment of Heart Failure) trial is a prospective, randomized, controlled, double-blind, multicentre trial that aims to assess the safety and efficacy of using the Reveal LINQ™ insertable cardiac monitor (ICM) in patients with HF to continuously monitor and evaluate HF risk status and guide timely interventions.
Methods: The ICM algorithm uses parameters derived from electrocardiogram (atrial fibrillation [AF], ventricular rate during AF, heart rate variability, and night heart rate), three-axis accelerometer (patient activity duration), and subcutaneous bioimpedance (fluid volume, respiration rate).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!